Related Experiment Videos
The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic
British Journal of Haematology
|April 1, 1985
Summary
Myelodysplastic syndrome (MDS) evolution patterns predict acute myeloid leukemia (AML) progression. Stable disease with no abnormal localization of immature myeloid precursors (ALIP) indicates better survival, while clone instability and new cytogenetic anomalies signal abrupt AML shifts.
Area of Science:
- Hematology
- Oncology
- Cytogenetics
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- MDS is characterized by ineffective hematopoiesis and a significant risk of transformation to acute myeloid leukemia (AML).
- Understanding the patterns of MDS evolution is crucial for predicting prognosis and guiding treatment.
Purpose of the Study:
- To investigate serial morphological and cytogenetic changes in patients with myelodysplastic syndrome (MDS).
- To identify distinct patterns of MDS evolution and their correlation with progression to acute myeloid leukemia (AML).
- To assess the prognostic significance of abnormal localization of immature myeloid precursors (ALIP) and cytogenetic anomalies in MDS.
Main Methods:
- Serial morphological and cytogenetic investigations were performed on 46 patients diagnosed with MDS.
- Bone marrow blast percentages were determined sequentially to define evolution patterns.
- Patients were assessed for the presence of abnormal localization of immature myeloid precursors (ALIP) and karyotype anomalies at diagnosis.
Main Results:
- Three distinct patterns of MDS evolution were observed: stable disease (Pattern A), abrupt shift to AML (Pattern B), and gradual increase in blasts (Pattern C).
- Patients with Pattern A and no ALIP at diagnosis had prolonged survival (median 43 months), whereas ALIP-positive patients had shorter survival (median 14 months).
- Acquisition of new karyotypic anomalies during MDS was strongly associated with an abrupt shift to AML (Pattern B).
Conclusions:
- MDS evolution is characterized by proliferative capacity and clone instability, which are key determinants of disease course and outcome.
- The presence of ALIP and the acquisition of cytogenetic anomalies are important prognostic markers in MDS.
- Identifying specific evolution patterns can help predict AML transformation risk and patient survival.